You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

~ Buy the NEVANAC (nepafenac) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR NEVANAC

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for NEVANAC

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00332774 ↗	Nevanac 3-Month Safety Study With QID Dosing	Completed	Alcon Research	Phase 3	2006-02-01	The purpose of this study is to determine the safety of Nevanac 0.1% compared to Acular LS 0.4% and Vehicle in patients treated before cataract surgery and for approximately 90 days following surgery.
NCT00333255 ↗	Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery	Completed	Alcon Research	Phase 3	2005-09-01	The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension, 0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating inflammation in the eye.
NCT00347204 ↗	Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK	Completed	Allergan	Phase 4	2006-01-01	To determine the ability of two topical Nonsteroidal Anti-inflammatory drops (Acular LS & Nevanac) to help control pain following Photorefractive Keratectomy (PRK).
NCT00347204 ↗	Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK	Completed	Center For Excellence In Eye Care	Phase 4	2006-01-01	To determine the ability of two topical Nonsteroidal Anti-inflammatory drops (Acular LS & Nevanac) to help control pain following Photorefractive Keratectomy (PRK).
NCT00348582 ↗	Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery	Completed	Innovative Medical	Phase 4	1969-12-31	The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for NEVANAC

Condition Name

Chart
Table

Condition Name for NEVANAC
Intervention	Trials
Cataract	7
Macular Edema	3
Cataracts	2
Cystoid Macular Edema	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for NEVANAC
Intervention	Trials
Cataract	10
Macular Edema	7
Edema	5
Inflammation	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for NEVANAC

Trials by Country

Map
Table

Trials by Country for NEVANAC
Location	Trials
United States	9
Brazil	4
Malaysia	2
India	2
Mexico	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for NEVANAC
Location	Trials
Texas	3
Pennsylvania	2
California	1
Illinois	1
Michigan	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for NEVANAC

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for NEVANAC
Clinical Trial Phase	Trials
Phase 4	15
Phase 3	5
Phase 2	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for NEVANAC
Clinical Trial Phase	Trials
Completed	18
Unknown status	3
Recruiting	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NEVANAC

Sponsor Name

Chart
Table

Sponsor Name for NEVANAC
Sponsor	Trials
Alcon Research	4
Allergan	3
Innovative Medical	2
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for NEVANAC
Sponsor	Trials
Other	22
Industry	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.